COVID-19 risks
Oct. 19, 2022, midnight
In light of the fact that the global infection situation is generally improving, and that G7 countries have already stopped designating levels by country and region, all the new coronavirus infectious disease risk information will be issued on October 19. The world is uniformly set to level 1 (please be careful).
Aug. 24, 2022, midnight
On August 24, the infectious disease risk information for 41 countries was changed from level 3 (recommendation to avoid travel) to level 2 (please refrain from non-essential travel), and the infectious disease risk information for 55 countries/regions was changed to level 2. The level has been lowered from (Please refrain from unnecessary and non-urgent travel) to Level 1 (Please be careful).
July 25, 2022, midnight
On July 23, Director-General Tedros Adhanom Ghebreyesus of the World Health Organization (WHO) declared the global outbreak of monkeypox a "public health emergency of international concern." According to the WHO, more than 16,000 cases of monkeypox infection in 75 countries and regions have been reported so far, and the infection is spreading worldwide.
July 1, 2022, midnight
Although the infection status of the new corona varies depending on the situation in each country and region, the risk of death and aggravation has decreased, and deregulation at the water's edge and in Japan has also been seen, especially in countries where vaccination is progressing worldwide. I'm on the way. Based on these trends, the infectious disease risk information level is now available after comprehensively considering the actual conditions of each country / region, such as the status of infection, vaccination status, infectious disease control / medical system, and status of various measures in each country / region. Was reviewed.
May 26, 2022, midnight
Although the infection status of the new corona varies depending on the situation in each country and region, the number of new infections and deaths is declining worldwide, and the risk of death and aggravation is mainly in countries where vaccination is progressing. Is declining, and regulations are being relaxed at the water's edge and in Japan. Based on these trends, the infectious disease risk information level is now available after comprehensively considering the actual conditions of each country / region, such as the status of infection, vaccination status, infectious disease control / medical system, and status of various measures in each country / region. Was reviewed.
April 1, 2022, midnight
The level of infectious disease risk information should be reviewed after comprehensively considering the actual situation of each country / region, such as the number of newly infected people in each country / region, vaccination status, infectious disease control / medical system, and status of various measures. It was made. As a result, infectious disease risk information has been reduced from Level 3 "Recommendation for suspension of travel" to Level 2 "Please stop unnecessary and unurgent travel" in 106 countries.
Nov. 29, 2021, midnight
As the infection may spread further, please be informed and try to prevent the infection.
Nov. 29, 2021, midnight
As the infection may spread further, please be informed and try to prevent the infection.
Aug. 13, 2021, midnight
As the infection may spread further, please obtain the latest information and try to prevent the infection.
May 18, 2021, midnight
Coronavirus infections are still spreading worldwide, with more than 160 million confirmed infections and more than 3 million deaths worldwide. Although the number of infected people is decreasing in North America and Europe, the situation continues to require caution, such as the remarkable spread of infection in South Asia.
Based on this situation, the infectious disease risk information level in Cambodia, Sri Lanka, Seychelles, Saint Lucia, Thailand, East Timor, and Mongolia has been newly set to Level 2 by comprehensively considering various situations including the deterioration of the infection situation. "Please stop unnecessary and unurgent travel" has been raised to Level 3 "Travel Cancellation Recommendation".
Oct. 30, 2020, midnight
As the infection may spread further, please obtain the latest information and try to prevent the infection.
Travel advisories from local embassies and consulates
Information from the past two weeks.
Table of contents
- Nov. 20, 2024, 8:51 a.m. (Repost) Changes to Guam entry requirements (Guam-Commonwealth of the Northern Mariana Islands Visa Waiver Program)
- Nov. 20, 2024, 4:51 a.m. Alert: Confirmation of imported cases of Empox (clade 1) in the United States
- Nov. 20, 2024, 2:36 a.m. [Infectious disease information] Confirmation of imported cases of Empox Congo Basin (clade 1) in the United States
- Nov. 19, 2024, 10:11 a.m. <Warning>: Confirmation of imported cases of Empox (clade 1) in the United States
- Nov. 19, 2024, 8:41 a.m. Alert: Confirmation of imported cases of Empox (clade 1) in the United States
- Nov. 19, 2024, 7:56 a.m. [Warning] Confirmation of imported cases of Empox (clade 1) in the United States
(Repost) Changes to Guam entry requirements (Guam-Commonwealth of the Northern Mariana Islands Visa Waiver Program)
Nov. 20, 2024, 8:51 a.m.
1. Japanese nationals must have a passport and a customs declaration form (Electronic Customs Declaration Form "EDF"), as well as one of the following documents (1) through (3) to enter Guam.
(1) U.S. Visa (2) U.S. Visa Waiver Program (ESTA)
(3) Guam-Commonwealth of the Northern Mariana Islands Electronic Travel Authorization (G-CNMI ETA)
2. Japanese nationals are subject to the Guam-Commonwealth of the Northern Mariana Islands Visa Waiver Program, so if you travel to Guam or the Northern Mariana Islands, such as Saipan, for short-term business or tourist purposes using an airline that is a member of the program (JAL and United Airlines are members), you can obtain a Guam-Commonwealth of the Northern Mariana Islands electronic travel authorization "G-CNMI ETA" (free of charge) for stays of 45 days or less, even if you have not applied for or obtained a U.S. visa or ESTA.
3. If you are traveling to Guam using the Guam-Commonwealth of the Northern Mariana Islands Visa Waiver Program, you can choose to either obtain a G-CNMI ETA online in advance or submit the I-736 form at immigration until November 29, 2024. However, the I-736 form will be invalid for boarding aircraft arriving after midnight (Guam time) on November 30, 2024, so you will need to apply for and obtain a G-CNMI ETA online in advance.
In addition, if you are unable to enter Guam by November 29 due to flight delays or cancellations, your "I-736" document will become invalid and you will be denied entry. Those planning to enter Guam around November 29 are advised to avoid traveling using "I-736" and to obtain "ESTA" or "G-CNMI ETA" in advance.
4. The Guam Visitors Bureau website states the following:
(1) If you are traveling to Guam after November 30th and do not have a U.S. visa, ESTA, or G-CNMI ETA, you will be denied entry and will be deported to your country of origin, etc.
(2) It is recommended that you apply for a G-CNMI ETA at least seven days prior to boarding the aircraft, and must obtain it no later than five days prior.
5. Those who have already obtained a U.S. visa (including U.S. Green Card holders) or the U.S. Visa Waiver Program (ESTA) do not need to obtain a G-CNMI ETA or submit the I-736 form.
6. Please note that even if your G-CNMI ETA is approved, it does not guarantee your entry into Guam.
Guam-Commonwealth of the Northern Mariana Islands Electronic Travel Authorization (G-CNMI ETA) Application Website
https://g-cnmi-eta.cbp.dhs.gov/
For more information, please visit the Guam Visitors Bureau website.
https://www.visitguam.jp/planning/immigration-to-guam/
Consulate-General of Japan in Hagatna
TEL: +1(671)646-1290
Email:infocgj@ag.mofa.go.jp
*This email will be sent to the email address registered on your residence notification and Tabi-Regi.
*If you have completed the simple registration for TabiRegi and would like to change or stop receiving emails, please follow the procedure to stop receiving them from the URL below.
https://www.ezairyu.mofa.go.jp/tabireg/simple/delete
*If you have submitted a residence notification and are returning to your home state (moving to another state) or wish to change the information on your residence notification, please complete the procedure at the URL below.
https://www.ezairyu.mofa.go.jp/RRnet/residencereport/login
*In order to protect your family, friends, and colleagues in the event of a disaster or unrest, please encourage your acquaintances, business travelers, and tourists to file a Residence Notification (for stays of 3 months or more) or register with Tabi-Regi (for stays of less than 3 months) so that information on safety measures can reach as many people as possible.
Alert: Confirmation of imported cases of Empox (clade 1) in the United States
Nov. 20, 2024, 4:51 a.m.
On November 16, the US Centers for Disease Control and Prevention (CDC) announced that the first imported cases of Congo Basin (clade 1) Mpox virus had been confirmed in the United States.
Here is a summary of the CDC announcement:
(1) The California Department of Public Health has confirmed the first case of Congo Basin (clade 1) Empox infection in the United States. This case is associated with the spread of Empox in Central and East Africa. CDC has determined that the risk of community spread of clade 1 Empox remains low.
(2) The confirmed case is known to have recently traveled to East Africa (imported case). Upon returning to the United States, the patient was treated at a local health facility and is currently self-isolating at home. The patient was not receiving treatment for Empox, but his/her symptoms have improved. CDC is working with state public health officials to conduct an epidemiological investigation to identify contacts.
(3) General contact with others, such as that expected while traveling, does not generally pose a significant risk of infection. CDC guidance will not change while this incident is under investigation.
(Reference) To prevent infection with M-pox, the following is recommended:
- Avoid close contact with people who have symptoms.
- Avoid contact with items used by symptomatic people (clothing, bedding, toothbrushes, etc.)
-If you are eligible for the vaccine, talk to your health care provider.
(4) Regarding the Congo Basin strain (clade 1) of Empox in the Democratic Republic of the Congo, a Level 2 (Practice Enhanced Precautions) alert remains in place.
(Reference) CDC Health Information Notices (THNs: Travel Health Notices)
Level 4: Avoid All Travel
Level 3: Reconsider Nonessential Travel
Level 2: Practice Enhanced Precautions
Level 1: Practice Usual Precautions
(Reference link) CDC website
https://www.cdc.gov/media/releases/2024/s1116-california-first-clade.html
2. The Ministry of Foreign Affairs of Japan has issued a "Wide-area Infectious Disease Information: EMPOCS Alert" (declaration of a "Public Health Emergency of International Concern (PHEIC)"), so please also refer to this.
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C033.html
3. To prevent EMPOX, it is recommended to avoid contact with droplets and body fluids of people with symptoms and animals that may be carrying the EMPOX virus, and to practice hand hygiene using soap or an alcohol-based disinfectant.
[Consulate-General of Japan in Miami]
Consulate General of Japan in Miami
80 SW 8th Street, Suite 3200, Miami, FL 33130
Phone: 305-530-9090
Representative website: http://www.miami.us.emb-japan.go.jp
This email address is for sending only.
○This email is automatically sent to the email addresses registered in your residence notification, email newsletter, and Tabi-Regi.
If you have signed up for Tabi-Regi and would like to stop receiving emails, please follow the procedure to stop receiving emails from the URL below.
URL: https://www.ezairyu.mofa.go.jp/tabireg/simple/delete
[Infectious disease information] Confirmation of imported cases of Empox Congo Basin (clade 1) in the United States
Nov. 20, 2024, 2:36 a.m.
On November 16, the US Centers for Disease Control and Prevention (CDC) announced the first confirmed imported case of Mpox-Congo Basin (Clade 1, formerly known as monkeypox) in the United States, providing the following summary:
(1) The California Department of Public Health has confirmed the first case of Congo Basin (clade 1) Empox in the United States. This case is associated with the spread of Empox in Central and East Africa. CDC believes the risk of community spread of clade 1 Empox remains low. (2) The patient has been confirmed to have recently traveled to East Africa (imported case). The patient was treated at a local health facility upon return to the United States and is currently self-isolating at home. Although he or she did not receive treatment for Empox, his or her symptoms have improved. CDC is working with state public health officials to conduct an epidemiological investigation to identify contacts.
(3) General contact with others, such as that expected during travel, does not typically pose a significant risk of infection. CDC guidelines will not change while this case is under investigation.
(4) Regarding the Congo Basin strain (clade 1) of Empox in the Democratic Republic of the Congo, a Level 2 (Practice Enhanced Precautions) alert remains in place.
(Reference) CDC Health Information Notices (THNs: Travel Health Notices)
Level 4: Avoid All Travel
Level 3: Reconsider Nonessential Travel
Level 2: Practice Enhanced Precautions
Level 1: Practice Usual Precautions
(Reference link) CDC website https://www.cdc.gov/media/releases/2024/s1116-california-first-clade.html
2. The mortality rate of cases infected with the Congo Basin Virus (clade 1) has been reported to be around 10%. As a preventative measure, it is recommended to avoid contact with droplets and body fluids of symptomatic people and animals that may carry the EMPOX virus, and to sanitize your hands with soap or an alcohol-based disinfectant. For more information on EMPOX, please refer to the following Ministry of Foreign Affairs Infectious Disease Information.
・M-pox Warning (dated August 8th):
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C032.html
- Caution regarding M-pox (Declaration of a Public Health Emergency of International Concern (PHEIC)) (dated August 16th):
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C033.html
*This email address is for sending only.
*This email is automatically sent to the email address registered in your residence notification, email newsletter, and Tabi-Regi.
*If you have signed up for TabiRegi and would like to stop receiving emails, please follow the procedure to stop receiving emails from the URL below.
URL: https://www.ezairyu.mofa.go.jp/tabireg/simple/delete
*In order to protect your family, friends and colleagues in the event of a disaster or unrest, please encourage your acquaintances, business travelers and tourists to file a Residence Notification (for stays of 3 months or more) or register for a Tabi-Regi (for stays of less than 3 months) so that information on safety measures can reach as many people as possible.
******************************************************
Consulate-General of Japan in Houston
Consulate-General of Japan in Houston
2 Houston Center, Suite 3000, 909 Fannin Street, Houston, Texas 77010
Phone: 713-652-2977 (Main) 24-hour emergency response
https://www.houston.us.emb-japan.go.jp/index_j.htm
<Warning>: Confirmation of imported cases of Empox (clade 1) in the United States
Nov. 19, 2024, 10:11 a.m.
On November 16, the US Centers for Disease Control and Prevention (CDC) announced that the first imported cases of Congo Basin (clade 1) Mpox virus had been confirmed in the United States.
The overview is as follows:
(1) The California Department of Public Health has confirmed the first case of Congo Basin (clade 1) Empox infection in the United States. This case is associated with the spread of Empox in Central and East Africa. CDC has determined that the risk of community spread of clade 1 Empox remains low.
(2) The confirmed case is known to have recently traveled to East Africa (imported case). Upon returning to the United States, the patient was treated at a local health facility and is currently self-isolating at home. The patient was not receiving treatment for Empox, but his/her symptoms have improved. CDC is working with state public health officials to conduct an epidemiological investigation to identify contacts.
(3) General contact with others, such as that expected while traveling, does not typically pose a significant risk of infection. CDC guidelines will not change while this incident is under investigation.
(4) Regarding the Congo Basin strain (clade 1) of Empox in the Democratic Republic of the Congo, a Level 2 (Practice Enhanced Precautions) alert remains in place.
(Reference) CDC Health Information Notices (THNs: Travel Health Notices)
Level 4: Avoid All Travel
Level 3: Reconsider Nonessential Travel
Level 2: Practice Enhanced Precautions
Level 1: Practice Usual Precautions
(Reference link) CDC website
https://www.cdc.gov/media/releases/2024/s1116-california-first-clade.html
2. The Ministry of Foreign Affairs of Japan has currently issued a "Wide-area Infectious Disease Information: EMPOCS Alert" (declaration of a "Public Health Emergency of International Concern (PHEIC)"), so please also refer to this.
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C033.html
3. To prevent EMPOX, it is recommended to avoid contact with droplets and body fluids of people with symptoms and animals that may be carrying the EMPOX virus, and to practice hand hygiene using soap or an alcohol-based disinfectant.
Alert: Confirmation of imported cases of Empox (clade 1) in the United States
Nov. 19, 2024, 8:41 a.m.
[Main text]
1. On November 16, the US Centers for Disease Control and Prevention (CDC) announced that the first imported case of Congo Basin (clade 1) Mpox virus was confirmed in the US. The details are as follows:
(1) The California Department of Public Health has confirmed the first case of Congo Basin (clade 1) Empox infection in the United States. This case is associated with the spread of Empox in Central and East Africa. CDC has determined that the risk of community spread of clade 1 Empox remains low.
(2) The confirmed case is known to have recently traveled to East Africa (imported case). Upon returning to the United States, the patient was treated at a local health facility and is currently self-isolating at home. The patient was not receiving treatment for Empox, but his/her symptoms have improved. CDC is working with state public health officials to conduct an epidemiological investigation to identify contacts.
(3) General contact with others, such as that expected while traveling, does not typically pose a significant risk of infection. CDC guidelines will not change while this incident is under investigation.
(4) Regarding the Congo Basin strain (clade 1) of Empox in the Democratic Republic of the Congo, a Level 2 (Practice Enhanced Precautions) alert remains in place.
(Reference) CDC Health Information Notices (THNs: Travel Health Notices)
Level 4: Avoid All Travel
Level 3: Reconsider Nonessential Travel
Level 2: Practice Enhanced Precautions
Level 1: Practice Usual Precautions
(Reference link) CDC website
https://www.cdc.gov/media/releases/2024/s1116-california-first-clade.html
2. The Ministry of Foreign Affairs of Japan has issued a warning regarding infectious disease: EMPOCS (declaration of a Public Health Emergency of International Concern (PHEIC)), so please refer to this as well.
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C033.html
3. To prevent EMPOX, it is recommended to avoid contact with droplets and body fluids of symptomatic people and animals that may carry the EMPOX virus, and to practice hand hygiene using soap or an alcohol-based disinfectant.
Consulate-General of Japan in Atlanta
Consulate General of Japan in Atlanta
Phipps Tower Suite 850
3438 Peachtree Road
Atlanta, GA 30326
TEL: (404) 240‐4300
EMAIL: ryoji@aa.mofa.go.jp
[Warning] Confirmation of imported cases of Empox (clade 1) in the United States
Nov. 19, 2024, 7:56 a.m.
[Main text]
On November 16, the U.S. Centers for Disease Control and Prevention (CDC) announced that the first imported case of clade I mpox (formerly monkeypox), a severe strain of the virus spreading in Africa, had been confirmed in the United States.
https://www.cdc.gov/media/releases/2024/s1116-california-first-clade.html
The patient has been confirmed to have been in East Africa (imported case), received treatment at a medical institution after entering the United States, and is currently in home isolation.
3. The CDC has stated that the risk of the spread of this clade 1 EMPOCH virus in the United States remains low, and has not changed its alert level (Level 2: Practice Enhanced Precautions).
[Reference] CDC Health Information Notices (THNs: Travel Health Notices)
Level 4: Avoid All Travel
Level 3: Reconsider Nonessential Travel
Level 2: Practice Enhanced Precautions
Level 1: Practice Usual Precautions
4. Please take sufficient preventive measures, such as paying attention to hygiene management such as washing your hands, gargling, and disinfecting your hands, and avoiding close contact (contact with droplets, bodily fluids, etc.) with people who have symptoms of MPOX, such as fever or rash.
5. The Ministry of Foreign Affairs of Japan has currently issued a "Wide-area Infectious Disease Information: EMPOCS Alert" (declaration of a "Public Health Emergency of International Concern (PHEIC)"), so please also refer to this.
https://www.anzen.mofa.go.jp/info/pcwideareaspecificinfo_2024C033.html
【reference】
What is M-pox? (National Institute of Infectious Diseases)
https://www.niid.go.jp/niid/ja/kansennohanashi/12052-mpox-intro.html
This email is automatically sent to the email address provided in your residence notification or the email address registered with Tabi-Regi.
[Contact Information]
Consulate-General of Japan in New York
299 Park Avenue 18th Floor, New York, NY 10171
TEL:(212)-371-8222
HP: http://www.ny.us.emb-japan.go.jp/jp/html/
*If you have registered with TabiRegi and do not wish to receive emails, please follow the procedure to change or stop receiving emails at the URL below.
(Change) https://www.ezairyu.mofa.go.jp/tabireg/simple/auth
(Stop) https://www.ezairyu.mofa.go.jp/tabireg/simple/delete
*If you have submitted a "Notification of Residence" and have returned to your home country or moved to another country (state), please submit a Notification of Return to Japan or Movement at the following URL.
https://www.ezairyu.mofa.go.jp/RRnet/residencereport/login
*In order to protect your family, friends, and colleagues in the event of a disaster or unrest, please tell your acquaintances, business travelers, and tourists to file a Residence Notification (for stays of 3 months or more) or register for Tabi-Regi (for stays of less than 3 months) so that information on safety measures can reach as many people as possible.
